The Invesco Perpetual European High Income Fund aims to achieve a high level of income and capital growth through a portfolio of primarily European equity and fixed interest securities.
Name | % Net Assets |
---|---|
Roche | 4.3% |
SLM SEK FRN 15/6/2010 | 2.9% |
Koninklijke KPN | 2.6% |
Novartis | 2.2% |
Vivendi Universal | 1.8% |
Telekom Austria | 1.8% |
Rexam 6.75% € Bonds 29/6/2017 | 1.8% |
GDF Suez | 1.8% |
Banque Cantonale Vaudoise | 1.8% |
John Lewis 8.375% £ Bonds 8/4/2019 | 1.7% |
Key | % Net Assets |
---|---|
Roche | 4.3% |
SLM SEK FRN 15/6/2010 | 2.9% |
Koninklijke KPN | 2.6% |
Novartis | 2.2% |
Other | 88% |
Date | 19-Aug-2022 |
---|---|
NAV | 133.08p |
Currency | GBP |
Change | -0.20p |
% | -0.15% |
YTD change | 133.08p |
YTD % | n/a |
Fund Inception | 01/05/2008 |
---|---|
Fund Manager | n/a |
TER | 1.01 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.02% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research